Advanced Search

per page
  Report Title Date Provider Type Pgs Price

ZIOPHARM Oncology Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

18 Apr 2014 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - ZIOPHARM ONCOLOGY, INC. (ZIOP-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

24 Apr 2014 Thomson Reuters Stock Report 11 $25.00

ValuEngine Detailed Valuation Report for ZIOP

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

24 Apr 2014 ValuEngine, Inc. 11 $25.00

ZIOP: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

24 Apr 2014 New Constructs, LLC 5 $25.00

ZIOPHARM Oncology, Inc. (ZIOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ZIOPHARM Oncology, Inc. (ZIOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary ZIOPHARM Oncology, Inc. (...

21 Apr 2014 GlobalData 28 $250.00

Wright Investors Service Comprehensive Report for Ziopharm Oncology, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

20 Apr 2014 Wright Reports 41 $75.00


19 Apr 2014 S&P Capital IQ Quantitative Report 10 $115.00

ZIOPHARM ONCOLOGY INC (ZIOP) 12-months forecast

", the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

19 Apr 2014 Pechala's Reports 1 $15.00

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of ZIOPHARM ONCOLOGY INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

18 Apr 2014 Jefferson Research 11 $20.00

Emergence of an Elite Immunotherapy Specialist

17 Apr 2014 Griffin Securities, Inc. 17 $138.00